‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
Beyond the arrhythmia, AF often signals broader pathological processes that impair cardiac function and reduce quality of life and life expectancy.5 Many of these conditions are closely linked to social determinants of health, disproportionately affecting populations with socioeconomic disadvantage. Effective AF management requires addressing both the arrhythmia and its underlying contributors.4 
C – Comorbidity and risk factor management
WarfarinHotline data reveals Australians’ pharmacy questions
What are the health questions Australian most want answers to? Data from Medicines Line, the NPS MedicineWise pharmacist-staffed information hotline, has revealed common medical...
Complementary medicines: Heart failure
Heart failure (HF), also referred to as congestive cardiac failure, is present in 1–2% of the Australian population.1 It is the end result of...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Aged care in focus
The Royal Commission into Aged Care Quality and Safety has heard clear calls for pharmacists, as a priority, to spend more time on the...
PSA’s national guidelines on MHR
It's been described as a 'game changer' for pharmacists and now there's a practical guide to unlocking the potential of My Health Record.
PSA's new...
Drivers’ prescription drug use under greater scrutiny
Pharmacists face new challenges when it comes to advising patients how prescription drug-use could affect their driving performance.
A change to the legal definition...
